Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
San Antonio Breast Cancer Symposium
Benefit for T-DM1 Confirmed
San Antonio Breast Cancer Symposium
Read More ›
Tamoxifen or Anastrozole for DCIS? Age and Symptom Profiles Matter
By
Jack Cuzick, PhD
San Antonio Breast Cancer Symposium
Read More ›
ESR1 Mutations Portend Worse Survival in ER+ Advanced Breast Cancer
By
Sarat Chandarlapaty, MD, PhD
San Antonio Breast Cancer Symposium
Read More ›
Early Results with Immunotherapy in Breast Cancer
By
Hope S. Rugo, MD
San Antonio Breast Cancer Symposium
Read More ›
Omit Chemotherapy for Premenopausal Luminal A Breast Cancer?
By
Torsten O. Nielsen, MD, PhD
San Antonio Breast Cancer Symposium
Read More ›
News from the 2013 San Antonio Breast Cancer Symposium
Conference News
,
San Antonio Breast Cancer Symposium
Read More ›